ÍøºìºÚÁÏ

Skip to main content
(352) 265-8940

Amir M Emtiazjoo, MD, MSc

Critical Care Medicine Specialist, Pulmonologist (Lung Specialist)

Photo of Amir M Emtiazjoo
(352) 265-8940 MyUFÍøºìºÚÁÏ

Research at a glance

Top areas of exploration

  • Lung Transplantation , 21 publications
  • Disease Models, Animal , 6 publications
  • Extracorporeal Membrane Oxygenation , 5 publications
  • Respiratory Insufficiency , 4 publications

Research activity

42 publications

419 citations

Why is this important?

Active clinical trials

BOSTON 3

The objective of the trial is to assess the long-term safety and efficacy of L-CsA plus Standard of Care (SoC) in the treatment of BOS in single (SLT) and double lung transplant (DLT) recipients.

Investigator
Amir M Emtiazjoo
Status
Accepting Candidates
Ages
18 Years - N/A
Sexes
All

My publications

42 publications

2021

A novel injury site-natural antibody targeted complement inhibitor protects against lung transplant injury.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons

•

2021

In vivo reprogramming of pathogenic lung TNFR2+ cDC2s by IFNβ inhibits HDM-induced asthma.

Science immunology

•

2021

Macrophage activating syndrome causing decompensated right heart failure.

Respiratory medicine case reports

•

2021

Set Up for Failure: Pre-Existing Autoantibodies in Lung Transplant.

Frontiers in immunology

•

2021

Successful Preoperative Optimization for Lung Transplantation With Transcatheter Mitral Valve Repair.

The Annals of thoracic surgery

•